Erratum: Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. The Hypoxia-Adenosine Link during Myocardial Ischemia-Reperfusion Injury.Biomedicines · 2022
   Review
2. Enteric glial adenosine 2B receptor signaling mediates persistent epithelial barrier dysfunction following acute DSS colitis.Mucosal immunology · 2022
   Article
3. Control of Gut Inflammation by Modulation of Purinergic Signaling.Frontiers in immunology · 2020
   Review
4. Targeting Hypoxia Signaling for Perioperative Organ Injury.Anesthesia and analgesia · 2018
   Review
5. Hypoxia-inducible factors as molecular targets for liver diseases.Journal of molecular medicine (Berlin, Germany) · 2016
   Review
6. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression.The Journal of clinical investigation · 2016
   Article

Corrections and comments

• Erratum for
  Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis.2015

Authors and funding

17 authors.

Funding

Abstract

PubMed holds no abstract for this paper.